Title: Principal Scientist
Company: Stablix, Inc.
Location: Needham, Massachusetts, United States
Benjamin Levin, principal scientist at Stablix, Inc., has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in the scientific community.
Dr. Levin’s professional journey is characterized by a steadfast commitment to advancing science and innovation. His educational foundation began with a Bachelor of Science in chemistry from the University of Rochester in 2007. Following this, he went on to earn a PhD in chemistry from Boston University in 2013.
Following his academic pursuits, he embarked on a series of impactful roles. Beginning his career as a postdoctoral scholar at Dartmouth College from 2013 to 2014, he laid the foundation for his subsequent roles. Following this, he contributed significantly as a research scientist at X-Chem, Inc. from 2015 to 2020, where he also served as an Independent Contractor in 2015.
Continuing his trajectory, Dr. Levin then assumed the role of a senior scientist and global protein lead at Dewpoint Therapeutics from 2020 to 2022. He also held a senior scientist position at Stablix, Inc. from 2022 to 2023, before transitioning to his current role as a principal scientist at Stablix, Inc. in 2023.
In addition to his professional endeavors, Dr. Levin actively engages in community service, volunteering in the local Jewish community, and maintaining membership in the American Chemical Society. His contributions to scientific literature underscore his dedication to advancing knowledge in the field, with publications such as “Influence of Heme c Attachment on Heme Conformation and Potential,” “Methionine Ligand Lability of Homologous Monoheme Cytochromes c,” and “Methionine Ligand Lability in Bacterial Monoheme Cytochromes c: An Electrochemical Study.”
With a strong sense of civic engagement and a commitment to scientific excellence, Dr. Levin continues to make meaningful contributions to both his profession and his community. He attributes his success to the support of his parents, who instilled in him the importance of perseverance and learning from failure. He aspires to start his own biotechnology company, where he aims to lead a larger team and deliver life-changing drugs to patients. His passion for science, coupled with his dedication to making a positive impact, positions him as a driving force in both scientific innovation and community service.
For more information, please visit:
Contact Dr. Levin:
